INTS9 inhibitors are a class of chemical compounds that specifically target and inhibit the function of the INTS9 protein, a subunit of the Integrator complex. The Integrator complex is a multi-subunit protein assembly that plays a critical role in the regulation of gene expression, particularly by interacting with RNA polymerase II during transcription. INTS9, as one of the subunits of this complex, is involved in the processing of small nuclear RNAs (snRNAs) and the termination of non-coding transcription. By inhibiting INTS9, these compounds can alter the normal activity of the Integrator complex, leading to disruptions in RNA processing and transcription regulation. The specificity of INTS9 inhibitors allows them to interfere with distinct steps in the transcriptional process, making them valuable tools for studying gene expression and RNA biology.
Inhibitors of INTS9 are often utilized in molecular biology to dissect the roles of individual subunits of the Integrator complex. By selectively inhibiting INTS9, researchers can investigate how its suppression affects RNA processing pathways and gene regulation at a transcriptional level. These inhibitors may be synthesized with varying levels of specificity and potency, depending on the structural composition and binding affinity for the INTS9 protein. Through structural biology and biochemical studies, it is possible to understand the mechanisms by which these inhibitors interact with INTS9 and their downstream effects on gene transcription. In this way, INTS9 inhibitors serve as powerful molecular tools to probe the intricate mechanisms of RNA transcription and processing.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Inhibits RNA Polymerase II (Pol II), potentially affecting snRNA processing and integrator complex function. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
Affects transcription elongation by Pol II, potentially influencing integrator complex functions. | ||||||
Flavopiridol Hydrochloride | 131740-09-5 | sc-207687 | 10 mg | $317.00 | ||
Cyclin-dependent kinase inhibitor, could affect transcription regulation and impact INTS9. | ||||||
RGFP966 | 1357389-11-7 | sc-507300 | 5 mg | $115.00 | ||
Selective inhibitor of histone deacetylase 3 (HDAC3), may indirectly affect transcription and INTS9 activity. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
HDAC inhibitor, potentially influencing chromatin structure and integrator complex function. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
Broad HDAC inhibitor, might affect chromatin structure and transcription, indirectly impacting INTS9. | ||||||
CPI-203 | 1446144-04-2 | sc-501599 | 1 mg | $170.00 | ||
Inhibits CREB binding protein (CBP)/p300, potentially impacting transcription regulation and INTS9 function. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
Inhibits BET bromodomain proteins, could affect transcription and thus INTS9 activity. | ||||||
THZ1 | 1604810-83-4 | sc-507542 | 1 mg | $95.00 | ||
CDK7 inhibitor, affecting transcription initiation and elongation, may influence INTS9. | ||||||
Pladienolide B | 445493-23-2 | sc-391691 sc-391691B sc-391691A sc-391691C sc-391691D sc-391691E | 0.5 mg 10 mg 20 mg 50 mg 100 mg 5 mg | $299.00 $5699.00 $11099.00 $25500.00 $66300.00 $2875.00 | 63 | |
Inhibits the spliceosome, potentially affecting processes relevant to INTS9. | ||||||